208 related articles for article (PubMed ID: 21935715)
1. Valuing EQ-5D using time trade-off in France.
Chevalier J; de Pouvourville G
Eur J Health Econ; 2013 Feb; 14(1):57-66. PubMed ID: 21935715
[TBL] [Abstract][Full Text] [Related]
2. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
4. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
[TBL] [Abstract][Full Text] [Related]
5. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
6. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states.
Lee YK; Nam HS; Chuang LH; Kim KY; Yang HK; Kwon IS; Kind P; Kweon SS; Kim YT
Value Health; 2009; 12(8):1187-93. PubMed ID: 19659703
[TBL] [Abstract][Full Text] [Related]
7. Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.
Bansback N; Tsuchiya A; Brazier J; Anis A
PLoS One; 2012; 7(2):e31115. PubMed ID: 22328929
[TBL] [Abstract][Full Text] [Related]
8. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
9. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
10. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.
Luo N; Wang P; Thumboo J; Lim YW; Vrijhoef HJ
Pharmacoeconomics; 2014 May; 32(5):495-507. PubMed ID: 24519603
[TBL] [Abstract][Full Text] [Related]
11. [General population time trade-off values for 42 EQ-5D health states in South Korea].
Jo MW; Lee SI
J Prev Med Public Health; 2007 Mar; 40(2):169-76. PubMed ID: 17426430
[TBL] [Abstract][Full Text] [Related]
12. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
13. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
[TBL] [Abstract][Full Text] [Related]
14. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
15. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
[TBL] [Abstract][Full Text] [Related]
16. The valuation of the EQ-5D in Portugal.
Ferreira LN; Ferreira PL; Pereira LN; Oppe M
Qual Life Res; 2014 Mar; 23(2):413-23. PubMed ID: 23748906
[TBL] [Abstract][Full Text] [Related]
17. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.
Shah K; Mulhern B; Longworth L; Janssen MF
Value Health; 2016 Jan; 19(1):53-9. PubMed ID: 26797236
[TBL] [Abstract][Full Text] [Related]
18. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.
Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O;
Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952
[TBL] [Abstract][Full Text] [Related]
19. Argentine valuation of the EQ-5D health states.
Augustovski FA; Irazola VE; Velazquez AP; Gibbons L; Craig BM
Value Health; 2009 Jun; 12(4):587-96. PubMed ID: 19900257
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
